Literature DB >> 16297560

Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain.

Ya-Chun Chu1, Yun Guan, John Skinner, Srinivasa N Raja, Roger A Johns, Yuan-Xiang Tao.   

Abstract

Nitric oxide (NO) acts as a neurotransmitter or neuromodulator involving in the modulation of thermal and/or inflammatory hyperalgesia. The neuronal nitric oxide synthase (nNOS) is a key enzyme for NO production in normal neuronal tissues, but its functional role in chronic pain remains unclear. The present study combined a genetic strategy with a pharmacologic approach to address the role of nNOS in the central mechanism of complete Freund's adjuvant (CFA)-induced chronic inflammatory pain. Targeted disruption of the nNOS gene significantly reduced CFA-induced mechanical pain hypersensitivity during the maintenance (but not the development) of inflammatory pain, while it failed to attenuate either development or maintenance of CFA-induced thermal pain hypersensitivity. Intraperitoneal administration of L-N(G)-nitro-arginine methyl ester (L-NAME), a non-specific NOS inhibitor, blocked CFA-evoked thermal and mechanical pain hypersensitivity at both development (2h) and maintenance (24h) phase in wild type mice, but had no effect in the knockout mice. Furthermore, intrathecal injection of either L-NAME or 7-nitroindazole, a selective nNOS inhibitor, markedly attenuated mechanical pain hypersensitivity at both 2 and 24h after CFA injection. Finally, spinal cord nNOS (but not endothelial NOS or inducible NOS) expression was up-regulated at 24h after CFA injection, occurring mainly in the ipsilateral superficial dorsal horn. Together, these data indicate that spinal cord nNOS may be essential for the maintenance of mechanical pain hypersensitivity and that it may also be sufficient for the development of mechanical pain hypersensitivity and for the development and maintenance of thermal pain hypersensitivity after chronic inflammation. Our findings suggest that spinal cord nNOS might play a critical role in central mechanisms of the development and/or maintenance of chronic inflammatory pain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297560     DOI: 10.1016/j.pain.2005.09.024

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  41 in total

1.  Effects of multiple intrathecal administration of L-arginine with different doses on formalin-induced nociceptive behavioral responses in rats.

Authors:  Kuan Li; Wen-Xiu Qi
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

2.  PDZ domains at excitatory synapses: potential molecular targets for persistent pain treatment.

Authors:  Yuan-Xiang Tao; Roger A Johns
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

3.  Nitric oxide inhibits nociceptive transmission by differentially regulating glutamate and glycine release to spinal dorsal horn neurons.

Authors:  Xiao-Gao Jin; Shao-Rui Chen; Xue-Hong Cao; Li Li; Hui-Lin Pan
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

Review 4.  Updated role of nitric oxide in disorders of erythrocyte function.

Authors:  Marc J Kahn; Jason H Maley; George F Lasker; Philip J Kadowitz
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2013-03-01

5.  Treatment with a carbon monoxide-releasing molecule inhibits chronic inflammatory pain in mice: nitric oxide contribution.

Authors:  Roger Negrete; Arnau Hervera; Sergi Leánez; Olga Pol
Journal:  Psychopharmacology (Berl)       Date:  2013-10-11       Impact factor: 4.530

6.  MBD1 Contributes to the Genesis of Acute Pain and Neuropathic Pain by Epigenetic Silencing of Oprm1 and Kcna2 Genes in Primary Sensory Neurons.

Authors:  Kai Mo; Shaogen Wu; Xiyao Gu; Ming Xiong; Weihua Cai; Fidelis E Atianjoh; Emily E Jobe; Xinyu Zhao; Wei-Feng Tu; Yuan-Xiang Tao
Journal:  J Neurosci       Date:  2018-09-28       Impact factor: 6.167

7.  Endogenous nitric oxide inhibits spinal NMDA receptor activity and pain hypersensitivity induced by nerve injury.

Authors:  Shao-Rui Chen; Xiao-Gao Jin; Hui-Lin Pan
Journal:  Neuropharmacology       Date:  2017-07-25       Impact factor: 5.250

8.  Reversal of NO-induced nociceptive hypersensitivity by St. John's wort and hypericin: NF-κB, CREB and STAT1 as molecular targets.

Authors:  Nicoletta Galeotti; Carla Ghelardini
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

Review 9.  Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain.

Authors:  Abhilasha Ahlawat; Ajay Rana; Nidhi Goyal; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2014-08-06       Impact factor: 4.473

10.  Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice.

Authors:  Yong Chen; Michael K Boettger; Andreas Reif; Angelika Schmitt; Nurcan Uçeyler; Claudia Sommer
Journal:  Mol Pain       Date:  2010-03-02       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.